top of page
top1_edited_edited_edited_edited_edited.

WE ARE POWERING BIOMOLECULAR
DISCOVERY  

Developing breakthrough technology is at our core. We help our customers accelerate

the delivery of better products. 

DESIGN. BUILD. REVOLUTIONISE. TOGETHER

Zyboscript is a biotechnology company founded in 2019 developing proprietary technologies in cell free protein synthesis with a vast array of applications in diagnostics, drug discovery and personalised medicine. Alongside our technology development pipeline, we offer specialised contract research and product development services. With our experienced team, well-equipped laboratory and deep domain knowledge, we are pioneering a new generation of molecular tools to help make discoveries that were once beyond reach.

shutterstock_606379010.jpg

HOW WE DO IT

We push beyond traditional boundaries by integrating our capabilities in rapid experimental biology, automation and machine learning optimisation to provide our partners better products, faster. 

Our high throughput platform opens up an expanded parameter space for deep biological insight, allowing us to find robust solutions to fulfil your project needs.

WHAT WE DO

We partner with you from concept to commercialisation to accelerate the delivery of next generation solutions. Use our pre-built solutions or work with us to bring a new disruptive technology to market.

We work with partners across the medical device, molecular diagnostics and drug discovery sectors to revolutionise patient testing and therapeutics.

shutterstock_1897204018.jpg
OUR
PLATFORM

Navigate the protein sequence space with CLARiTY   

TM

multiwell reaction plate

At our core is CLARiTY   , a novel eukaryotic cell free protein synthesis platform. It is designed for rapid expression of simple-to-complex proteins, including antibodies and enzymes, and those that cannot be expressed in living cells. 

 

Rapid, reliable, cost-effective and scalable, CLARiTY    is the ideal platform for high throughput screening of protein variant libraries. With access to a near limitless diversity in protein sequence, CLARiTY    enables discoveries 10X-100X faster compared to traditional cell-based expression systems. 

TM

TM

TM

OUR
SOLUTIONS
icon-2-white.png

Molecular diagnostics

Let us build your single or multiplex assay for fast, sensitive and robust detection of any target nucleic acid from any organism or sample type.

Molecular diagnostics

icon-1white.png

Protein expression

Quickly express your protein in our high throughput in vitro assays to probe biomolecular interactions and accelerate hit discovery. 

icon-3-white.png

Protein engineering

Rapidly identify your best performing protein with large scale combinatorial sequence variant libraries and ribosome display technology. 

ITL_logo_C_colour.png
OUR
PARTNERS
ITL_logo_C_colour.png

Zyboscript has assisted us with the development of new diagnostic devices. Their molecular diagnostics capabilities have proved invaluable in pushing projects forward. The Zyboscript team are professional, diligent, and thorough, and we are very happy to leverage their expertise to accelerate the development of new and innovative products.

Mark Tickner, Lead Project Manager 

 

WE'RE ACCELERATING

DISCOVERY

Sign up now to hear the latest news and insights from Zyboscript. 

REVOLUTIONISE

WITH

US

Zyboscript Limited
The Glassworks
Mill Bay, Folkestone
Kent CT20 1JG
United Kingdom

info@zyboscript.co.uk
CROPPED zyboscript logo black BG less co
© 2024 Zyboscript Ltd. All Rights Reserved.
bottom of page